Keywords: aventis, gains, approval, lantus, pharma, gained, market

Aventis gains US approval for Lantus

Article | 27 April 2000

Print This

Aventis Pharma has gained US approval to market Lantus (insulinglargine [rDNA origin] injection) for the once-daily treatment of both type 1 ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in